The Role of Levamisole in the Adjuvant Treatment of Stage III Colon Cancer Patients: A Randomized Trial of 5-Fluorouracil and Levamisole Versus 5-Fluorouracil Alone

Cancer Investigation

Volumn 21, Issue 5, 2003, Pages 701-707

  Cascinu, Stefano ^a   Catalano, Vincenzo ^a   Piga, Andrea ^a   Mattioli, Rodolfo ^a   Marcellini, Massimo ^a   Pancotti, Amedeo ^a   Bascioni, Romeo ^a   Torresi, Umberto ^a   Silva, Rosa Rita ^a   Pieroni, Vitaliano ^a   Giorgi, Francesca ^a   Catalano, Giuseppina ^a   Cellerino, Riccardo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

5 Fluorouracil; Colon cancer; Levamisole; Stage C

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BILIRUBIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; LEVAMISOLE;

ADULT; AGED; ANXIETY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CARDIOVASCULAR DISEASE; CEREBELLAR ATAXIA; CLINICAL TRIAL; COLON ADENOCARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART DISEASE; HUMAN; IRRITABILITY; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INJECTIONS, INTRAVENOUS; LEVAMISOLE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0242496960     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120023769     Document Type: Article

References (19)

1. Moertel, C.G.; Fleming, T.R.; MacDonald, J.S.; Haller, D.G.; Laurie, J.A.; Goodman, P.J.; Ungerleider, J.S.; Emerson, W.A.; Tormey, D.C.; Glick, J.H.; Veeder, M.H.; Mailliard, J.A. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 1990, 322, 352-358.
2. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990, 264, 1444-1450.
3. Takimoto, C.H. Enigma of fluorouracil and levamisole. J. Natl Cancer Inst. 1995, 87, 471-473.
4. Zalcberg, J.R.; Siderov, J.; Simes, J. The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer. Ann. Oncol. 1996, 7, 41-46.
5. Wolmark, N.; Rockette, H.; Mamounas, E.; Jones, J.; Wieand, S.; Wickerham, D.L.; Bear, H.D.; Atkins, J.N.; Dimitrov, N.V.; Glass, A.G.; Fisher, E.R.; Fisher, B. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J. Clin. Oncol. 1999, 17, 3553-3559.
6. Haller, D.G.; Catalano, P.J.; MacDonald, J.S. Fluorouracil, leucovorin and levamisole adjuvant therapy for colon cancer: five-year final report of INT-0089. Proc. Am. Soc. Clin. Oncol. 1998, 17, 982.
7. Kaplan, E.L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958, 53, 457-481.
8. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 1966, 50, 163-170.
9. Buyse, M.; Zeleniuch-Jacquotte, A.; Chalmers, T.C. Adjuvant therapy of colorectal cancer, why we still don't know. JAMA 1988, 259, 3571-3578.
10. Gray, R.; James, R.; Mossman, J.; Stenning, S. Axis-a suitable case for treatment. Br. J. Cancer 1991, 63, 851-855.
11. Buroker, T.R.; Moertel, C.G.; Fleming, T.R.; Everson, L.K.; Cullinan, S.A.; Krook, J.E.; Mailliard, J.A.; Marschke, R.F.; Klaassen, D.J.; Laurie, J.A. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma. J. Clin. Oncol. 1985, 3, 1624-1628.
12. Arnaud, J.P.; Buyse, M.; Nordlinger, B.; Martin, F.; Pector, J.C.; Zeitoun, P.; Adloff, A.; Duez, N. Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Br. J. Surg. 1989, 76, 284-289.
13. Haller, D.G. An overview of adjuvant therapy for colorectal cancer. Eur. J. Cancer 1995, 31A, 1225-1263.
14. Bandealy, M.T.; Gonin, R.; Loherer, P.J.; Monaco, F.; Einhorn, L.H. Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group Trial. Clin. Cancer Res. 1998, 4, 935-939.
15. Grage, T.B.; Moss, S.E. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospective controlled randomized trial. Surg. Clin. N. Am. 1981, 61, 1321-1329.
16. International Multicentre Pooled Analysis of Colorectal Cancer Trials (IMPACT) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995, 345, 939-944.
17. Laurie, J.A.; Moertel, C.G.; Fleming, T.R.; Willand, H.S.; Leigh, J.E.; Rubin, J.; McCormack, G.W.; Gerstner, J.B.; Kwok, J.E.; Mailliard, J.; Twito, D.I.; Morton, R.F.; Tschetter, L.K.; Barlow, J.F. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J. Clin. Oncol. 1989, 7, 1447-1456.
18. QUASAR Collaborative Group. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet 2000, 355, 1588-1596.
19. O'Connel, M.J.; Laurie, J.A.; Kahn, M.; Fitzgibbons, R.J.; Erlichman, C. ; Sheperd, L.; Moertel, C.G.; Kocha, W.I.; Pazdur, R.; Wieand, H.S.; Rubin, J.; Vukov, A.M.; Donohue, J.H.; Krook, J.E.; Figueredo, A. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J. Clin. Oncol. 1998, 16, 295-300.